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Background. Klebsiella pneumoniae is an opportunistic pathogen and leading cause of hospital-associated infections. Intensive 
care unit (ICU) patients are particularly at risk. Klebsiella pneumoniae is part of the healthy human microbiome, providing a poten-
tial reservoir for infection. However, the frequency of gut colonization and its contribution to infections are not well characterized.
Methods. We conducted a 1-year prospective cohort study in which 498 ICU patients were screened for rectal and throat car-
riage of K. pneumoniae shortly after admission. Klebsiella pneumoniae isolated from screening swabs and clinical diagnostic samples 
were characterized using whole genome sequencing and combined with epidemiological data to identify likely transmission events.
Results. Klebsiella pneumoniae carriage frequencies were estimated at 6% (95% confidence interval [CI], 3%–8%) among ICU 
patients admitted direct from the community, and 19% (95% CI, 14%–51%) among those with recent healthcare contact. Gut col-
onization on admission was significantly associated with subsequent infection (infection risk 16% vs 3%, odds ratio [OR] = 6.9, P 
< .001), and genome data indicated matching carriage and infection isolates in 80% of isolate pairs. Five likely transmission chains 
were identified, responsible for 12% of K. pneumoniae infections in ICU. In sum, 49% of K. pneumoniae infections were caused by 
the patients’ own unique strain, and 48% of screened patients with infections were positive for prior colonization.
Conclusions. These data confirm K. pneumoniae colonization is a significant risk factor for infection in ICU, and indicate ~50% 
of K. pneumoniae infections result from patients’ own microbiota. Screening for colonization on admission could limit risk of infec-
tion in the colonized patient and others.
Keywords. Klebsiella pneumoniae; gastrointestinal colonization; genomic epidemiology; intensive care; hospital acquired 
infection.
 
The emergence of multidrug-resistant (MDR) Klebsiella pneumo-
niae has resulted in a dramatic increase in research into reservoirs 
and risk factors for healthcare-associated (HA) K.  pneumoniae 
infections, largely focused on extended spectrum beta-lactamase 
(ESBL) or carbapenemase-producing (CP) bacteria isolated from 
infections and intrahospital outbreaks [1–3]. These studies have 
demonstrated transmission of ESBL or CP K. pneumoniae between 
patients and show that gastrointestinal (GI) tract colonization with 
ESBL or CP K. pneumoniae can be a risk factor for infection [3, 4]. 
Yet although the majority of K. pneumoniae HA infections are not 
ESBL or CP [5, 6], there are little data on the frequency and clinical 
relevance of colonization with K. pneumoniae more generally.
Klebsiella pneumoniae is known to asymptomatically colonize 
the skin, mouth, respiratory and GI tracts, although few studies 
address this specifically. Using culture-free methods, K. pneumo-
niae was detected in approximately 10% of Human Microbiome 
Project samples from the mouth, nares, and skin, and 3.8% of 
stool samples [7]. Using bacteriological culture, a 2010 study 
detected nasopharyngeal carriage in 15% of Indonesian adults 
and 7% of children [8], whereas a 2014 study detected naso-
pharyngeal carriage in 2.7% of Vietnamese adults and throat 
carriage in 14% [9].
Patients suffering from CP K. pneumoniae infections (typically 
ST258), or from pyogenic liver abscess caused by hypervirulent 
K. pneumoniae (ST23), have been shown to carry their infecting 
strain in their GI tract for between 30 days (≤74%) and 6 months 
(<30%) following discharge from hospital [10]. However, the 
question of whether K. pneumoniae colonization on admission 
to hospital poses a risk for subsequent infection is much less 
clear. A 1971 study found 18.5% of patients admitted to various 
wards in the Denver Veterans Administration Hospital were cul-
ture-positive for rectal carriage of K. pneumoniae, and carriage 
was significantly associated with risk of subsequent HA infection 
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(45% vs 11%) [11]. A 2016 study at the University of Michigan 
Health System tertiary care hospital reported similar coloniza-
tion rates (23%) and increased risk of infection following coloni-
zation (5.2% in colonized vs 1.3% in noncolonized) [12].
Here, we assessed the prevalence of K.  pneumoniae colo-
nization in an at-risk cohort in an intensive care unit (ICU) 
within a modern, well-equipped, and well-managed tertiary 
teaching hospital in Australia. Additionally, we investigated 
whether colonization on admission enhances risk of subsequent 
K. pneumoniae infection among ICU patients and the relative 
contribution of patients’ own gut microbiota and intra-hospital 
transmission to the burden of K.  pneumoniae carriage and 
infection in the ICU.
METHODS
Ethics
Ethical approvals for these studies were granted by the Alfred 
Hospital Ethics Committee (project numbers 550/12 and 
526/13).
Recruitment and Specimen and Data Collection
The Klebsiella Acquisition Surveillance Project at Alfred Health 
(KASPAH) was conducted from April 1, 2013, to March 31, 
2014. Eligible patients (adults aged ≥18 years and expected to 
spend ≥3 days in ICU) were recruited as soon as possible after 
admission, and baseline rectal and throat screening swabs were 
collected. For the first 9  months verbal consent was required 
to participate. For the last 3  months a universal surveillance 
study for multidrug resistant organisms was conducted for 
which consent was waived; samples and data from this period 
were also included in KASPAH (see Supplementary Methods 
and Supplementary Figure 1). Follow-up swabs were repeated 
each 5–7 days after baseline for the duration of ICU stay and 
up to 4  days following transfer to another ward. Information 
on age, sex, dates of hospital and ICU admission/s, surgery 
in the last 30 days, and antibiotic treatment in the last 7 days 
were extracted from hospital records at the time each swab was 
taken. Dates of discharge and/or death were extracted from 
hospital records at the conclusion of the study. All clinical iso-
lates recovered from ICU patients and identified as K. pneumo-
niae infections by the hospital diagnostic laboratory as part of 
routine care were included in the study. Full details are given in 
Supplementary Methods.
Community Associated vs Healthcare Associated Carriage
Individuals in the community-associated (CA) screening group 
include patients who were both (i) admitted to the Alfred 
Hospital ICU either directly (day 0) or via another ward on day 
0, 1, or 2 of the original hospital admission; and (ii) first swabbed 
on day 0, 1, or 2 of that admission. Patients first swabbed on day 
3 or later of their hospital admission are included in the HA/Day 
3+ screening group. Individuals referred to the Alfred Hospital 
ICU by the trauma ward of another hospital were assumed to be 
emergency admissions from the community and were assigned 
to the CA/Day 0–2 or HA/Day 3+ screening groups according 
to the day of first swab relative to their Alfred Hospital admis-
sion. All other patients transferred from another hospital were 
included in the HA/D3+ screening group. As such, the CA/Day 
0–2 screening groups represent individuals admitted directly to 
the hospital from the community, whereas the HA/D3+ group 
includes individuals with recent hospital exposure.
DNA Extraction and Sequencing
DNA was extracted from overnight cultures using a phe-
nol:chloroform protocol and phase lock gel tubes and 
sequenced via Illumina HiSeq to generate 125  bp paired-end 
reads (see Supplementary Methods). Following quality control 
checks of the sequence data, 148 isolates from 106 patients were 
subjected to comparative genomic analysis (see Supplementary 
Table  1 for genome sequence accessions). A  maximum likeli-
hood phylogenetic tree was inferred from an alignment of all 
single-nucleotide polymorphisms (SNPs) identified within core 
K.  pneumoniae genes using FastTree v2.1.8 [13, 14]. Lineages 
were defined based on this tree using RAMI [15] and multilocus 
sequence types were assigned using SRST2 [16]. Isolates falling 
within the same lineage were further investigated to identify 
pairwise SNPs via assembly and read mapping; full details of 
genomic analyses are given in Supplementary Methods.
Statistical Analysis
All statistical analyses were conducted using R (v3.3.1) (details 
in Supplementary Methods).
RESULTS
Klebsiella pneumoniae Carriage
A total of 498 patients expected to spend ≥3  days in ICU 
were recruited and screened for K. pneumoniae carriage. This 
represents 33% of eligible patients during the consent-based 
recruitment period and 75% in the universal surveillance 
period (18% of all ICU admissions in the study period). Fifty-
four patients (10.8%) tested positive at baseline screening (50 
GI carriage only, 2 throat carriage only, 2 both). Carriage was 
detected at the same frequency in males and females (11.0% 
vs 10.4%; P  =  .9), and the median age of carriers was mod-
erately higher than that of carriage-negative participants 
(67 vs 58  years, Supplementary Figure  2; P  =  .06, Wilcoxon 
rank-sum test).
We estimated the rate of CA K.  pneumoniae GI carriage, 
among patients recruited and swabbed in the ICU within 
2  days of their first recorded admission to the Hospital (CA/
D0-2 group), to be 5.9% (95% confidence interval [CI], 3% – 
8%, Table 1, Supplementary Table 2). The HA GI carriage rate, 
among patients who were first swabbed in the ICU on or after 
the third day of admission to the Alfred hospital or following 
210 • CID 2017:65 (15 July) • Gorrie et al
referral from another hospital (HA/D3+ group, Supplementary 
Figure  3), was significantly higher at 19% (95% CI, 13.6% – 
25.7%, odds ratio [OR] = 3.75, P = .00001).
One third of the participants in the ICU screening study 
(n  =  170) contributed 1 or more follow-up screening swabs 
(Table 1). The overall GI carriage rate at follow-up was 15.3% 
(n = 26/170), similar to the HA GI carriage rate of 19% (OR = 1.3; 
95% CI, 0.71–2.38). Participants testing positive on follow-up 
rectal swabs included 19 who tested negative for K. pneumoniae 
on their baseline rectal swab, yielding a conversion rate of 12%.
None of the 19 CA baseline carriage isolates were MDR 
(Table 1). GI carriage of MDR strains was detected at similar 
rates among HA baseline isolates (18%, including 4 ESBL and 
2 CP isolates, all in patients who had received antibiotics in the 
last 7 days) and follow-up screening isolates (16% of patients, 
including 4 with ESBL and 1 with CP isolates). A total of seven 
patients contributed both baseline and follow-up GI carriage 
isolates (Table 1). For 5/7 patients the resistance profiles for the 
follow-up isolate remained the same as the baseline isolate, and 
for 2/7 patients the follow-up isolate was more resistant (see 
Supplementary Tables 1 and 3).
GI Colonization Is a Source of Klebsiella Infection
A total of 49 patients (1.8% of all adult ICU admissions) who 
spent time in the ICU during their hospital stay were identified 
as having K. pneumoniae infections (11 ESBL, of which 3 were 
also CP). Most (n = 38) were in the ICU when the K. pneumo-
niae–positive diagnostic specimen was taken, and 10 were in 
another ward shortly after transfer from ICU. Pneumonia was 
the most frequent form of K.  pneumoniae infection in ICU 
patients (60%), followed by wound infections (15%), nondis-
seminated urinary tract infection (UTI) (10%), and bacteremia 
with sepsis (8%). MDR was most common among wound and 
blood isolates (≥50%) (Table 2).
To assess whether K. pneumoniae GI carriage on admission 
to ICU was a risk factor for subsequent K. pneumoniae infec-
tion during hospital stay, we examined the subset of 491 indi-
viduals whose baseline screening swab was obtained at least 
2 days prior to collection of any clinical specimen from which 
K. pneumoniae was isolated (Figure 1). The rate of K. pneumo-
niae infection was significantly higher among patients who 
were culture-positive for GI carriage at baseline compared to 
those who were culture-negative (16% vs 3%; OR  =  6.9, 95% 
Table 1. Klebsiella pneumoniae GI Carriage Detected at Baseline and Followup Screening of Alfred Hospital Patients
Baseline Carriage Status Number of Patients (%) MDR Isolates (%) Follow-up +ve (%) Follow-up MDR (%)
CA/Day 0–2 324
 Baseline Kp +ve 19 (5.9%) 0 (0%) 2/4 (50%) 0 (0%)
 Baseline Kp −ve 305 (94.1%) … 14*/96 (14.6%) 0 (0%)
HA/Day 3+ 174
 Baseline Kp +ve 33 (19%) 6 (17.6%) 5/13* (38.5%) 2 (40%)
 Baseline Kp −ve 141 (81%) … 5/57 (8.8%) 2 (40%)
Total baseline Kp +ve 52 (10.4%) 6 (11.3%) 7/17 (41.2%) 2 (28.6%)
Total baseline Kp −ve 446 (89.6%) … 19/153 (12.4%) 2 (10.5%)
Total 498 6 (1.2%) 26/170 (15.3%) 4 (15.4%)
Patient groups: ICU CA/Day 0–2, rectal screening swab obtained on day 0, 1, or 2 of admission to Alfred Hospital and not referred from another hospital (except from trauma unit); ICU HA/
Day 3+, rectal screening swab obtained on day 3 or later of admission to Alfred Hospital or referred from another hospital. *These indicate 2 patients from whom swabs yielded isolates that 
were identified in the hospital laboratory as K. pneumoniae, but sequencing of subcultures identified substantial E. coli, indicating likely presence of both species.
Abbreviations: GI, gastrointestinal; ICU, intensive care unit; MDR, multidrug-resistant.
Table 2. Patients With Infection(s) and Time in the ICU
Pneumonia UTI (Non-invasive) Wound Other Bacteremia With Sepsis Total
Recipient in transmission chain 2 1 2 0 1 6
Donor in transmission chain 3 0 1 0 0 4
Prior GI colonization 6 1 1 0 0 8
Prior throat colonization 1 0 0 0 0 1
Unknown source (unique lineage) 16 (12) 3 (3) 4 (1) 3 (2) 3 (1) 29
Total 28 (5 MDR) 5 8 (4 MDR) 3 4 (2 MDR) 48
Type of infection and source of infection outlined (position/presence in transmission chain, prior colonization, unknown). Note that 3 patients had UTI and bacteremia with sepsis; they are 
represented here in the bacteremia with sepsis column. “Unknown source” includes those infections for which there is no genetic or epidemiological evidence to indicate whether the 
infection has arisen from a patient’s own carriage strains or through transmission from another source; numbers in brackets indicate the number of such infections associated with a lineage 
that was unique to that patient. Note that “unknown source” also includes one patient who had a wound infection diagnosed as K. pneumoniae but genome sequencing found the subcul-
tured isolate to be dominated by A. baumannii DNA; this is consistent with mixed infection or contamination, and prevents reliable comparative analysis with other K. pneumoniae strains.
Abbreviations: GI, gastrointestinal; ICU, intensive care unit; MDR, multidrug-resistant; UTI, urinary tract infection.
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Screened for baseline 
carriage
n = 498 Excluded as baseline screening
occurred ≤2 days prior to 
infection
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n = 491
n = 7
Baseline carriage No baseline carriage
Infection Infection
MDR infection MDR infection
n = 49
n = 8 (16%)
n = 442
n = 12 (3%)
n = 5 n = 3
Figure 1. Flowchart outlining number of patients included in each part of carriage rates analyses.
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Figure 2. Genome diversity of isolates from ICU patients identified as Klebsiella pneumoniae. All trees are maximum likelihood trees inferred from core genome SNP 
alignments. Scale bars indicate average number of substitutions per site across the genome. Tip colours indicate isolate source as per inset legend. *Possible mixed isolate 
(0.02–0.1 het/hom SNP ratio, excluded from pairwise SNP analysis in Figure 3). **Clinical isolate from sputum (KC0048), may not represent an infection. Phylogenetic line-
ages to which more than one ICU isolate belongs are highlighted and labeled with their corresponding multi-locus sequence type (ST) and the total number of SNPs identified 
between isolates in the lineage; darker shading indicates multiple patients contributed isolates in that cluster, as per inset legend. (A), Unrooted tree of all isolates, revealing 
three distinct species that are typically identified as K. pneumoniae in diagnostic laboratories. (B), Midpoint rooted species tree for K. variicola isolates. (C), Midpoint rooted 
species tree for K. pneumoniae sensu stricto isolates. Abbreviations: ICU, intensive care unit; SNP, single-nucleotide polymorphism.
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CI, 2.3 – 19.7, P < .001, see Figure 1). Of all ICU patients who 
developed K. pneumoniae infections and contributed baseline 
screening swabs, 48% (n = 13/27) tested positive for K. pneu-
moniae GI carriage at baseline (including 8 who were screened 
>2 days prior to developing the infection).
To determine whether infections were caused by patients’ 
own colonizing bacteria and to identify transmission between 
ICU patients, we sequenced the genomes of all K.  pneumo-
niae isolated from patients who had spent any time in the ICU 
during their hospital stay(s). A total of 143 high-quality whole 
genome sequences were obtained from 106 patients, including 
56 clinical, 80 GI carriage, and 7 throat carriage isolates. Core 
genome phylogenetic analysis (Figure 2) revealed the presence 
of 61 lineages of K. pneumoniae sensu stricto (n = 111 isolates) 
and 24 lineages of 2 closely related species: 20 K. variicola line-
ages (n = 28 isolates) and 4 K. quasipneumoniae lineages (n = 4 
isolates). The average distance between lineages within each 
species was 0.5% nucleotide divergence, representing thousands 
of years of evolutionary separation based on molecular clock 
estimates for K. pneumoniae [17].
Most Klebsiella lineages (n = 69/85, 81%) were identified in just 
1 patient, and 60% of patients (n = 64) had their own unique lin-
eage not observed in any other patients (Figure 2, Supplementary 
Table 3). Half the infections (n = 24/48) were caused by a lineage 
unique to the patient. Fifteen patients had both GI carriage and 
infection isolates available for genome comparison; 12 of these 
pairs matched at the lineage level (including 6 patients whose car-
riage isolate was collected >2 days prior to the infection).
Klebsiella Transmission in the ICU
Sixteen Klebsiella lineages were detected in more than 1 patient 
(dark shading, Figure 2). Lineage sharing between patients could 
result from recent transmission of bacteria within the hospital 
(strain sharing) or by independent acquisition of a lineage that has 
been circulating in the community (lineage sharing). To distin-
guish these possibilities we compared intra-patient and inter-pa-
tient pairwise SNP distances (Figure 3). Intra-patient genetic 
distances were nearly all (97%) less than 25 SNPs per 5 Mbp, 
and most (82%) were less than 10 SNPs, whereas inter-patient 
genetic distances ranged from 0 to >5000 SNPs (Figure 3). Using 
25 and 10 SNPs per 5 Mbp as cut-offs to indicate likely and very 
likely strain sharing between patients, we identified 5 groups of 
ICU patients that likely shared Klebsiella strains. Strikingly, each 
of these groups comprised patients with overlapping admissions, 
making them epidemiologically plausible intra-hospital trans-
mission chains (Figure 4). For the other 11 lineages that were 
detected in more than 1 ICU patient, between-patient SNP dis-
tances exceeded 80 SNPs per 5 Mbp and ICU admissions were 
generally nonoverlapping (Supplementary Figure 4). Six infec-
tion episodes (n = 6/49, 12%) were attributable to these intra-hos-
pital transmission chains (n = 4 ST681 [K. variicola], n = 1 ST323, 
n = 1 ST231; Figure 4). These included 2 episodes of pneumonia, 
2 wound infections, and 2 UTIs, one of which disseminated to 
cause bacteremia with sepsis (Table 2, Supplementary Table 3). 
Of the 4 donors in the transmission chains, 3 had pneumonia 
and 1 had a wound infection. Most of the infections associated 
with transmission were MDR (3/4 donors and 3/6 recipients), 
yielding a strong association between MDR infections and trans-
mission in the ICU (OR = 13.6, P = .002). In addition, we iden-
tified 4 patients whose K. pneumoniae carriage was attributable 
to intra-hospital transmission chains but did not result in any 
recorded K. pneumoniae infection during hospital stay (n = 1 
ST323 [MDR], n = 2 ST215 [non-MDR], n = 1 ST15 [MDR]), 
representing 5% of all carriage-positive patients.
DISCUSSION
We estimated a 5.9% CA rate for culture-positive GI carriage 
of K. pneumoniae, similar to the 3.9% estimated among healthy 
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Figure 3. Pairwise genetic distances between isolates belonging to the same lin-
eage, expressed as SNPs per 5 Mbp of genome in order to normalise for differences 
in shared gene content between strain pairs. Violin plots showing distribution of 
pairwise genetic distances intra- and inter-patient; black bars indicate the median 
value. Note the log10 scale which excludes display of 1 strain pair that was sepa-
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Klebsiella pneumoniae Infections in ICU • CID 2017:65 (15 July) • 213
individuals in the Human Microbiome Project based on 16S 
rRNA amplicon sequencing of stool samples [7]. HA carriage 
among ICU patients was estimated to be much higher at 19%, 
with 12% of patients converting from culture-negative at base-
line to culture-positive on follow-up. This likely reflects acqui-
sition of bacteria in the hospital (transmission of strains was 
directly observed in 5% of cases) and/or selection for growth of 
pre-existing K. pneumoniae in the GI microbiome during hos-
pitalization (MDR rate was 18% in HA baseline carriage and 
15% at follow-up, but MDR was not detected in CA baseline 
carriage). The HA rate estimated here is similar to the cul-
ture-positive GI carriage rates estimated in other hospital stud-
ies [11, 12].
Our data demonstrate that K. pneumoniae is a fairly common 
component of the human GI microbiome (5.9%) and of clinical 
significance in the ICU setting, as: (i) K. pneumoniae carriage on 
admission to ICU was significantly associated with subsequent K. 
pneumoniae infection (OR = 6.9, P = .0003), consistent with the 
results reported from the 1970s Denver study (OR = 4.0, P = .0009 
[11]) and the 2016 Michigan study (OR = 4.1, P = .00002 [12]); 
and (ii) the WGS data confirmed a direct link between coloniz-
ing and infecting strains in 13 patients (80% of those with paired 
isolates available for testing), also consistent with the Michigan 
study [12]. We found strong evidence that a large proportion of 
ICU K. pneumoniae infections are attributable to patients’ own 
GI microbiota: (i) of all 49 K. pneumoniae infections diagnosed in 
ICU patients during the study period, 49% were associated with 
K. pneumoniae lineages unique to the patient; and (ii) of the 27 
K. pneumoniae infections diagnosed in ICU patients from whom 
screening swabs were obtained, 48% occurred in patients who 
tested positive for prior GI colonization with K. pneumoniae. In 
contrast, only 12% of infections showed evidence of resulting 
from intra-hospital transmission in this setting. This suggests 
that although measures to reduce cross-contamination between 
patients are necessary, they are not sufficient to eliminate K. 
pneumoniae infections in hospitalized patients, and measures to 
minimize the risk of infection with the patients’ own microbiome 
deserves significant attention [21–23].
Figure 4. Timelines for all lineages detected in multiple patients that show any inter-patient pairwise genetic distance between isolates of ≤25 SNPs per 5 Mbp. Lineages 
are boxed and labeled with their multi-locus sequence type (ST). Each horizontal dashed line indicates the time line for a patient, labelled to the left (crosses indicate date of 
death where applicable). Periods of Alfred Hospital admission are indicated as white boxes, periods in ICU as pink shading. Circles indicate K. pneumoniae infection isolates 
(red, belonging to the lineage; black, other lineage); triangles indicate rectal screening swabs (red, K. pneumoniae belonging to the lineage; black, K. pneumoniae of another 
lineage; unfilled, negative for K. pneumoniae). Orange boxes indicate groups of isolates for which all patients have at least one pairwise genetic distance of ≤10 SNPs per 
5 Mbp with another in the group; similarly for yellow (≤25 SNPs) and blue (≤100 SNPs) boxes. Abbreviations: ICU, intensive care unit; SNP, single-nucleotide polymorphism.
214 • CID 2017:65 (15 July) • Gorrie et al
Key strengths of this study are the prospective cohort design 
and the use of WGS to confirm species identification and strain 
relatedness for all K.  pneumoniae isolated from ICU patients, 
regardless of antimicrobial susceptibility. Most previous stud-
ies of K.  pneumoniae colonization in hospitals have focused 
on ESBL and/or CP isolates only, which do not represent the 
major burden of K. pneumoniae infections. WGS demonstrated 
that some isolates identified as K. pneumoniae by MALDI-TOF 
actually belonged to closely related groups that have recently 
been described as separate species [24], K.  quasipneumoniae 
and K.  variicola (Figure  2). Because these species are very 
closely related to K. pneumoniae sensu stricto (~4% nucleotide 
divergence), are clinically indistinguishable, and are typically 
identified as K. pneumoniae in diagnostic laboratories, compa-
rable studies reporting K. pneumoniae carriage encompass the 
entire K. pneumoniae complex. WGS also demonstrated that a 
small number of isolates identified as K. pneumoniae were con-
taminated to varying degrees with non-Klebsiella DNA (n = 6) 
or multiple Klebsiella strains (n = 8) (Supplementary Methods). 
These may reflect coinfection followed by selection for dif-
ferent subpopulations in the laboratory used for the different 
tests. These samples were therefore excluded from high-res-
olution genomic analysis for attribution purposes (Figure  1, 
Supplementary Table  1) but were included in calculation of 
overall rates of infection and carriage, which reflect solely the 
routine laboratory identification and are directly comparable 
with other reported results.
The main limitations of the study arise from the swabbing 
procedure to identify K.  pneumoniae colonization on admis-
sion. Efforts were made to collect swabs as soon as possible 
following admission; however, delays due to obtaining consent 
and avoiding patient care disruption meant that it was often 
not possible to obtain screening swabs on the day of admis-
sion. Notably, similar culture-positive rates were observed for 
swabs collected on day 0, 1, or 2 of admission (Supplementary 
Table 2), so it is unlikely that this had a significant impact on 
CA colonization results. Although the recruitment rate was 
low (33%) during the consent-based recruitment period, the 
demographic features and K. pneumoniae colonization rate in 
this group were not significantly different from those recruited 
under the universal surveillance protocol (75% recruitment; 
Supplementary Figure 1); hence, there is no evidence of signif-
icant selection bias. We used rectal swab culture to determine 
K. pneumoniae GI colonization status; however, although this 
approach is standard for pathogen carriage screening [25–27], 
its sensitivity to detect K. pneumoniae is not well characterized 
and likely depends on the K. pneumoniae strain, GI microbi-
ome composition, and recent antimicrobial exposures. There 
is likely a significant false negative rate. Hence our study 
probably underestimates the rate of colonization in the com-
munity and the contribution of colonisation to subsequent 
infection. Additionally, as only 1 isolate was stored from each 
K.  pneumoniae positive infection or carriage specimen, it is 
possible that the proportion of matching infection/carriage 
pairs underestimates the contribution of carriage to infection 
and misses some instances of transmission.
Our conclusion that the GI microbiome is a source of K. 
pneumoniae infections in ICU patients echoes similar findings 
that colonizing strains of S. aureus, A. baumannii, Enterococcus, 
and Enterobacteriaceae are a common source of HA infections 
[12, 23–25]. Routine screening for nasal carriage of methicil-
lin-resistant S. aureus or gut carriage of vancomycin-resistant 
Enterococcus or ESBL/CP Enterobacteriaceae has been intro-
duced in various hospital settings [25–28]. A recent study of 
CP K. pneumoniae in Israel suggested screening and isolation 
of carriers could help end current outbreaks and prevent future 
ones [3]. A similar study introduced screening for ESBL K. 
pneumoniae in order to limit and prevent current and future 
outbreaks [29]. Although those studies focus on screening for 
CP or ESBL K. pneumoniae, our results indicate that routine 
screening for general K. pneumoniae carriage in the ICU could 
also be a valuable tool. Foreknowledge of the antimicrobial 
susceptibility profiles of K. pneumoniae, as well as other oppor-
tunistic pathogens resident in the microbiome, could guide the 
choice of prophylactic and therapeutic antimicrobial treatment 
[21, 22, 25].
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so questions or comments should be addressed to the corresponding author.
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